Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_assertion type Assertion NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_head.
- NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_assertion description "[To determine whether or not the methylation status of blood leukocyte DNA can be used as a surrogate marker of the risk for cancer, we quantitatively determined the methylation levels of insulin-like growth factor 2 (IGF2) and TUSC3 in 299 gastric cancer cases, and 299 age- and gender-matched controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_provenance.
- NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_assertion evidence source_evidence_literature NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_provenance.
- NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_assertion SIO_000772 22447362 NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_provenance.
- NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_assertion wasDerivedFrom befree-20140225 NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_provenance.
- NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_assertion wasGeneratedBy ECO_0000203 NP317502.RA6FjqvMApCZ-_E4Pb0Jfc-VYYLFQRCvnY_dkrPYV0FNU130_provenance.